دورية أكاديمية

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis

التفاصيل البيبلوغرافية
العنوان: Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
المؤلفون: Fazia A. Mir, Alhareth Al Juboori, Jack D. Bragg, Veysel Tahan
المصدر: İstanbul Kuzey Klinikleri, Vol 5, Iss 1, Pp 64-66 (2018)
بيانات النشر: KARE Publishing, 2018.
سنة النشر: 2018
المجموعة: LCC:Medicine
LCC:Medicine (General)
مصطلحات موضوعية: autoimmune hemolytic anemia, inflammatory bowel disease, infliximab, ulcerative colitis., Medicine, Medicine (General), R5-920
الوصف: Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2148-4902
Relation: https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-77045; https://doaj.org/toc/2148-4902
DOI: 10.14744/nci.2017.77045
URL الوصول: https://doaj.org/article/97297667e0194d67b3f7f8a44ad73d2b
رقم الأكسشن: edsdoj.97297667e0194d67b3f7f8a44ad73d2b
قاعدة البيانات: Directory of Open Access Journals